Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aion Therapeutic Inc ANTCF


Primary Symbol: C.AION

Aion Therapeutic Inc is in the business of research and development, treatment, data mining and state-of-the-art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.


CSE:AION - Post by User

Aion Therapeutic Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(434)
•••
Post by Cherrypinkon Mar 16, 2021 2:28pm
217 Views
Post# 32809026

Mental Health Market

Mental Health MarketSponsored Post It was said that the growth potential for its shareholders today could be life-changing. This green leaf news might satisfy your interest. Check here.

According to report, psil-o-cybin is the latest plant-based organic compound researchers are proving to be powerfully effective in therapies for treating PTSD, opioid addictions, alcoholism and chronic depression/anxiety disorders.
 
It was said that in the United States, projections are that the pharmaceutical might uses for once vilified psych-e-delic and green leaf compounds could soar to approach a massive $60 billion market size. Check the disclaimer on profile and landing page.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities